BUD
Anheuser-Busch InBev SA/NV
There isn't enough reported data to score BUD yet.
BUD Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Unavailable | |
| Unavailable | |
| Unavailable |
There isn't enough reported data to rate BUD's fundamentals.
BUD PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 17x | N/A | N/A |
| Current | 18x | $83.85 | — |
| Fair | 21x | N/A | N/A |
| Expensive | 26x | N/A | N/A |
Historical ranges are pointers, not guarantees.
BUD's PE is 18x, but its earnings don't support one, so it isn't a reliable read right now.
BUD Forward outlook
There aren't enough analyst estimates for BUD to show an outlook.
BUD Earnings Per Share
BUD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $31.9B | +6.4% |
| Q4 2025 | $30.7B | +2.7% |
| Q2 2025 | $30B | +0.4% |
| Q4 2024 | $29.9B | -0.5% |
| Q2 2024 | $29.9B | +1.9% |
| Q4 2023 | $30B | +1% |
| Q2 2023 | $29.3B | +4.7% |
| Q4 2022 | $29.8B | +4.5% |
BUD's revenue has grown year over year for 11 quarters in a row: $31.9B last quarter, up 6.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 27% | +2 points |
| Q4 2025 | 26% | +2.4 points |
| Q2 2025 | 50% | +26 points |
| Q4 2024 | 27% | +1.7 points |
| Q2 2024 | 25% | +0.3 points |
| Q4 2023 | 23% | -2.2 points |
| Q2 2023 | 24% | -1.3 points |
| Q4 2022 | 25% | -3.3 points |
BUD's operating margin was 27% last quarter, up 2 points from the same quarter a year ago.
BUD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $3.8B | +193% |
| Q4 2025 | $9.9B | -4.2% |
| Q2 2025 | $1.3B | +58% |
| Q4 2024 | $10.4B | +13% |
| Q2 2024 | $831.7M | +$2B |
| Q4 2023 | $9.1B | +15% |
| Q2 2023 | -$1.2B | -$1.1B |
| Q4 2022 | $8B | +7.6% |
BUD generated $25.4B in free cash flow over the past year, up 52% from the year before.
BUD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +10% | +181M shares |
| 1 year | -3.2% | -65.3M shares |
| 3 years | +0.3% | +6.6M shares |
| 5 years | +20% | +336M shares |
| Available history | +23% | +376M shares |
BUD has 2B diluted shares, down 3.2% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | $1.3B |
| Q4 2025 | $400M |
| Q2 2025 | $1.9B |
| Q4 2024 | $99M |
| Q2 2024 | $836.7M |
| Q2 2023 | — |
| Q2 2022 | — |
| Q2 2021 | — |
BUD Net Leverage
BUD's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
BUD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.7 | Neutral |
| Stochastic | 74.5 | Neutral |
BUD's weekly RSI is 57 (neutral) and its Stochastic is 75 (neutral).
BUD PE vs Consumer Defensive Sector
| Metric | BUD | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 19x | 8.3% below |
| PE % | 21 | 18 | 3 pts above |
BUD is trading at 18x earnings, in line with the Consumer Defensive sector's median of 19x, though its earnings don't support one.
BUD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $80.5 | 4.2% above |
| 20 week MA | $80.6 | 4% above |
| 50 week MA | $76.5 | 9.6% above |
| 100 week MA | $68.8 | 22% above |
| 200 week MA | $64.5 | 30% above |
BUD is in an uptrend: it's above all five of its weekly moving averages, and 30% above its 200-week average.
BUD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $83.1 | $70.6 | -15% |
| 2021 | $70.6 | $60.8 | -14% |
| 2022 | $60.8 | $60.4 | -0.7% |
| 2023 | $60.4 | $64.6 | +7% |
| 2024 | $64.6 | $50.4 | -22% |
| 2025 | $50.4 | $64.2 | +28% |
| 2026 YTD | $64.2 | $83.9 | +31% |
BUD is up 31% so far in 2026, after finishing lower in four of the previous six years.